免疫疗法-话题@MedSci

#免疫疗法#

9篇内容 | 4304人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2170559, encodeId=8e4921e05593a, content=<a href='/topic/show?id=3c1ee4340c9' target=_blank style='color:#2F92EE;'>#神经母细胞瘤#</a> <a href='/topic/show?id=e6dd29094a1' target=_blank style='color:#2F92EE;'>#免疫疗法#</a> <a href='/topic/show?id=873310e78751' target=_blank style='color:#2F92EE;'>#PC-CAR T疗法#</a>, objectTitle=Nature：神经母细胞瘤的免疫新疗法：PC-CAR T疗法, objectType=article, longId=801566, objectId=fe0f801566b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=fe0f801566b2, replyNumber=0, likeNumber=109, createdTime=2023-11-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe0f801566b2, moduleTitle=Nature：神经母细胞瘤的免疫新疗法：PC-CAR T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe0f801566b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2163917, encodeId=d384216391eb5, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a>的<a href='/topic/show?id=e6dd29094a1' target=_blank style='color:#2F92EE;'>#免疫疗法#</a>, objectTitle=2023 SITC临床实践指南：黑色素瘤的免疫疗法（3.0版）, objectType=guider, longId=26692, objectId=2b8791c003a0532e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=2b8791c003a0532e, replyNumber=0, likeNumber=151, createdTime=2023-10-20, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2b8791c003a0532e, moduleTitle=2023 SITC临床实践指南：黑色素瘤的免疫疗法（3.0版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=2b8791c003a0532e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2155767, encodeId=d2682155e67d7, content=<a href='/topic/show?id=7692105e040' target=_blank style='color:#2F92EE;'>#KRAS抑制剂#</a>与<a href='/topic/show?id=e6dd29094a1' target=_blank style='color:#2F92EE;'>#免疫疗法#</a>组合治疗<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>临床试验开始, objectTitle=Cancer Cell：KRAS抑制剂与免疫疗法组合治疗胰腺癌临床试验开始, objectType=article, longId=789676, objectId=6454e8967636, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=6454e8967636, replyNumber=0, likeNumber=130, createdTime=2023-09-02, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6454e8967636, moduleTitle=Cancer Cell：KRAS抑制剂与免疫疗法组合治疗胰腺癌临床试验开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6454e8967636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1249508, encodeId=9a09124950852, content=<a href='/topic/show?id=e6dd29094a1' target=_blank style='color:#2F92EE;'>#免疫疗法#</a>, objectTitle=NEJM：Prasinezumab治疗帕金森病再度失败，aSyn靶向免疫疗法前路茫茫, objectType=article, longId=734861, objectId=5977e348614f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220804/b848703515154d0596c43fb8d8f402c8.jpg, objectUrl=/article/show_article.do?id=5977e348614f, replyNumber=0, likeNumber=112, createdTime=2022-09-17, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5977e348614f, moduleTitle=NEJM：Prasinezumab治疗帕金森病再度失败，aSyn靶向免疫疗法前路茫茫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5977e348614f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1249505, encodeId=185e1249505d4, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a><a href='/topic/show?id=e6dd29094a1' target=_blank style='color:#2F92EE;'>#免疫疗法#</a>, objectTitle=Nature Cancer：癌症免疫疗法可能会损害生育能力, objectType=article, longId=737159, objectId=1f35e371595d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220827/1661584190077_5295905.jpg, objectUrl=/article/show_article.do?id=1f35e371595d, replyNumber=0, likeNumber=144, createdTime=2022-09-17, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f35e371595d, moduleTitle=Nature Cancer：癌症免疫疗法可能会损害生育能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f35e371595d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=944154, encodeId=71a89441548b, content=免疫疗法进展迅速<a href='/topic/show?id=e6dd29094a1' target=_blank style='color:#2F92EE;'>#免疫疗法#</a>, objectTitle=NEJM：BCMA靶向CAR-T细胞疗法Idecabtagene Vicleucel（Ide-cel）取得积极结果, objectType=article, longId=207624, objectId=eba320e6248f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021225/1614255107497_5295902.jpeg, objectUrl=/article/show_article.do?id=eba320e6248f, replyNumber=0, likeNumber=184, createdTime=2021-02-28, rootId=0, userName=黄昏晓Time, userId=d98f5411800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eba320e6248f, moduleTitle=NEJM：BCMA靶向CAR-T细胞疗法Idecabtagene Vicleucel（Ide-cel）取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eba320e6248f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫疗法

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#神经母细胞瘤# #免疫疗法# #PC-CAR T疗法#

Nature：神经母细胞瘤的免疫新疗法：PC-CAR T疗法

2023-11-23发表于上海

litao2022 (审核中...)

前往app查看评论内容

#黑色素瘤#的#免疫疗法#

2023 SITC临床实践指南：黑色素瘤的免疫疗法（3.0版）

2023-10-20发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#KRAS抑制剂#与#免疫疗法#组合治疗#胰腺癌#临床试验开始

Cancer Cell：KRAS抑制剂与免疫疗法组合治疗胰腺癌临床试验开始

2023-09-02发表于上海

小小医者 (审核中...)

前往app查看评论内容

#免疫疗法#

NEJM：Prasinezumab治疗帕金森病再度失败，aSyn靶向免疫疗法前路茫茫

2022-09-17

小小医者 (审核中...)

前往app查看评论内容

#癌症##免疫疗法#

Nature Cancer：癌症免疫疗法可能会损害生育能力

2022-09-17

黄昏晓Time (审核中...)

前往app查看评论内容

免疫疗法进展迅速#免疫疗法#

NEJM：BCMA靶向CAR-T细胞疗法Idecabtagene Vicleucel（Ide-cel）取得积极结果

2021-02-28

科室
- - 订阅+
  - 更多科室
工具
服务